The 4th Commercializing Clinically Validated Digital Therapeutics Summit returns in December of 2021 as the only industry-led meeting deep-diving on stakeholder alliance and partnership to accelerate DTx scalability, to enable building sustainable & viable business models.
DTx is happening, and happening fast on a global scale. The amount of investment continues to surge, and is expected to reach $15,176m in 2027. Following the pandemic, with more emphasis on digital medicine, telemedicine, and decentralized clinical trials, DTx adoption has peaked. Now is the time to join with key stakeholders across regulatory, pricing, physician engagement, real world evidence, commercial functions, patient adherence and adoption to combat the challenges and ensure delivery of cutting edge DTx to your patients.
Furthermore, the pandemic has been the major catalyst to DTx adoption with tremendous benefits brought to patients, physicians for treatment, and remote clinical trials that made 2021 an inflection point for the DTx industry.
Across 3 days covering extensive and valuable content, we will bring together expert speakers to share their data on case studies of lessons learnt and keys to success, as well as insights into venturing into effective partnerships. This will give you the tools to conquer your most crucial challenges and accelerate sustainable scalability and adoption of your digital therapeutic.
Whether you are a drug, med device or a DTx developer, this is your must-attend event in 2021. Hear from your peers’ journeys and lessons learned, and re-engage in the long awaited dialogue to generate clinical and RWE, in order to serve our patients in need beyond just a pill!
To know more visit: https://ter.li/cyw0ze